These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 15783242)

  • 1. Safety profile of different low-molecular weight heparins used at therapeutic dose.
    Gouin-Thibault I; Pautas E; Siguret V
    Drug Saf; 2005; 28(4):333-49. PubMed ID: 15783242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis.
    Sobieraj DM; Coleman CI; Tongbram V; Chen W; Colby J; Lee S; Kluger J; Makanji S; Ashaye A; White CM
    Pharmacotherapy; 2012 Sep; 32(9):799-808. PubMed ID: 22744711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Hirsh J; Raschke R
    Chest; 2004 Sep; 126(3 Suppl):188S-203S. PubMed ID: 15383472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of low molecular weight heparins in the treatment of venous thromboembolism.
    Bernardi E; Prandoni P
    Expert Opin Drug Saf; 2003 Jan; 2(1):87-94. PubMed ID: 12904127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low molecular weight heparin and bleeding in patients with chronic renal failure.
    Crowther M; Lim W
    Curr Opin Pulm Med; 2007 Sep; 13(5):409-13. PubMed ID: 17940486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilisation and safety of low molecular weight heparins: prospective observational study in medical inpatients.
    Cestac P; Bagheri H; Lapeyre-Mestre M; Sié P; Fouladi A; Maupas E; Léger P; Fontan B; Massip P; Montastruc JL
    Drug Saf; 2003; 26(3):197-207. PubMed ID: 12580648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-molecular-weight heparins in the treatment of deep-vein thrombosis.
    Martineau P; Tawil N
    Ann Pharmacother; 1998 May; 32(5):588-98, 601. PubMed ID: 9606481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-molecular-weight heparins: are they interchangeable?
    van der Heijden JF; Prins MH; Büller HR
    Haemostasis; 2000; 30 Suppl 2():148-57; discussion 146-7. PubMed ID: 11251361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-molecular-weight heparins in renal impairment and obesity: available evidence and clinical practice recommendations across medical and surgical settings.
    Nutescu EA; Spinler SA; Wittkowsky A; Dager WE
    Ann Pharmacother; 2009 Jun; 43(6):1064-83. PubMed ID: 19458109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [State of the art: low-molecular-weight heparin and beyond].
    Cimminiello C; Casali G; Vitali L
    Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):61-5. PubMed ID: 11253343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low molecular weight heparins: are they superior to unfractionated heparins to prevent and to treat deep vein thrombosis?
    Boneu B
    Thromb Res; 2000 Oct; 100(2):V113-20. PubMed ID: 11053624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosing and monitoring of low-molecular-weight heparins in special populations.
    Duplaga BA; Rivers CW; Nutescu E
    Pharmacotherapy; 2001 Feb; 21(2):218-34. PubMed ID: 11213859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-molecular-weight heparin in patients with chronic renal insufficiency.
    Lim W
    Intern Emerg Med; 2008 Dec; 3(4):319-23. PubMed ID: 18563531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-molecular weight heparins in venous and arterial thrombotic disease.
    Bijsterveld NR; Hettiarachchi R; Peters R; Prins MH; Levi M; Büller HR
    Thromb Haemost; 1999 Sep; 82 Suppl 1():139-47. PubMed ID: 10695506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of thrombotic and cardiovascular disorders in the new millenium.
    Fareed J; Hoppensteadt DA; Bick RL
    Clin Appl Thromb Hemost; 2003 Apr; 9(2):101-8. PubMed ID: 12812377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bemiparin: a review of its use in the prevention of venous thromboembolism and treatment of deep vein thrombosis.
    Chapman TM; Goa KL
    Drugs; 2003; 63(21):2357-77. PubMed ID: 14524738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-molecular-weight heparins in the management of unstable angina.
    Agnelli G; Sonaglia F
    Haemostasis; 2000; 30 Suppl 2():158-67; discussion 146-7. PubMed ID: 11251362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low molecular weight heparin: a critical analysis of clinical trials.
    Green D; Hirsh J; Heit J; Prins M; Davidson B; Lensing AW
    Pharmacol Rev; 1994 Mar; 46(1):89-109. PubMed ID: 8190751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic equivalency of low-molecular-weight heparins.
    McCart GM; Kayser SR
    Ann Pharmacother; 2002 Jun; 36(6):1042-57. PubMed ID: 12022908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis.
    Lazrak HH; René É; Elftouh N; Leblanc M; Lafrance JP
    BMC Nephrol; 2017 Jun; 18(1):187. PubMed ID: 28592259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.